+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trial Supplies Market Analysis by Services, by Phase, by Type, by Therapeutic Area, by End use by Region - Global Forecast to 2029

  • PDF Icon

    Report

  • 154 Pages
  • August 2022
  • Region: Global
  • Quintana Research and Consulting
  • ID: 5651549
The clinical trial supplies market size is estimated to be USD 2.6 billion in 2021 and is expected to witness a CAGR of 10.84% during the forecast period 2022-2029. The rising R&D spending in pharmaceutical and biopharmaceutical firms, and the expanding number of clinical trials done internationally are the factors driving the market growth. However, rising cost of medication development and clinical trials is expected to limit the market growth.

By Services

Based on services, the market is segregated into storage & retention, logistics & distribution, comparator sourcing, packaging, labelling & blinding, manufacturing, and other services. In 2021, the logistics & distribution accounted for the highest revenue share due to the increased use of supply chain management and mobile technologies, and clinical trial globalization, and a rise in the number of clinical sites.

By Phase

On the basis of phase, the market is categorized into phase 1, phase 2, phase 3, phase 4, and BA/BE studies. In 2021, the phase 3 segment accounted for the highest revenue share owing to the significant demand for supply chain management in this phase.

By Type

Based on type, the market is segregated into biologic drugs, small molecule, and medical devices. In 2021, the small-molecule drugs segment accounted for the highest revenue share due to increasing investment in R&D by pharmaceutical and biotechnology companies.

By Therapeutic Area

On the basis of therapeutic area, the market is categorized into CNS and mental disorders, digestive disorders, blood disorders, cardiovascular disease, metabolic disorders, oncology, immunology, infectious disorders, and others. In 2021, the oncology segment accounted for the highest revenue share owing to the increasing incidence and prevalence of cancer, healthcare systems all over the world are concentrating on lowering the burden of cancer by using cutting-edge therapeutic and diagnostic methods, and numerous pharmaceutical companies in the creation of novel cancer treatments are making significant investments. However, the substantial and expanding body of research on cancer medicines and the growing number of businesses devoted to growing the oncology segment.

By End user

Based on end user, the market is segregated into medical device companies, biotechnology & pharmaceutical companies, and contract research organizations (CROS). In 2021, the biotechnology & pharmaceutical companies accounted for the highest revenue share due to the increased R&D operations.

Regional Markets

North America held the largest revenue share in the clinical trial supplies market in 2021, and it is predicted to continue to do so throughout the forecast period. This is due to increasing number of registered clinical trials in this region, significant investments in clinical trial R&D, and presence of numerous global pharmaceutical companies.

Competitor Insights

Some of the key players operating in the clinical trial supplies market are Thermo Fisher (US), Catalent, Inc. (US), Parexel (US), Eurofins (France) UDG Healthcare (Ireland), Piramal Pharma Solutions (India), Almac Group (UK), PCI Pharma Services (US), PRA Health Sciences (US), Biocair (UK), Eurofins (France), Marken (US), Infosys (India), Liveo Research (India), Capsugel (a Lonza Group company) (Switzerland), SIRO Clinpharm (India), KLIFO A/S (Denmark), Clinigen (UK), Ancillare (US), N-SIDE (Belgium), ADAllen (UK), Rubicon (India), Durbin (UK), Recipharm (Sweden), Seveillar (India), Myonex (India).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including anatomy, drug type, route of administration, purchasing pattern, and distribution channel from 2021 to 2029.

Segmentation: Osteoarthritis Therapeutics Market Report 2021-2029

By Anatomy (Revenue, USD Billion)

  • Hip Osteoarthritis
  • Knee Osteoarthritis
  • Small Joint Osteoarthritis
  • Hand Osteoarthritis

By Drug Type (Revenue, USD Billion)

  • Analgesics
  • Corticosteroids
  • Viscosupplementation Agents
  • Nonsteroidal Anti-inflammatory Drugs

By Route of Administration (Revenue, USD Billion)

  • Topical Route
  • Oral Route
  • Parenteral Route

By Purchasing Pattern (Revenue, USD Billion)

  • Prescription Drugs
  • Over-the-Counter Drugs

By Distribution Channel (Revenue, USD Billion)

  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

By Region (Revenue, USD Billion)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
1.4.1. Research Models
1.4.1.1. Bottom-up Approach
1.4.1.2. Top-down Approach
1.4.1.3. Data Triangulation
1.4.2. Data Procurement
1.4.2.1. Internal Database
1.4.2.2. Secondary Research
1.4.2.3. Purchased Database
1.4.2.4. Primary Research
1.4.3. Data Analysis
1.4.3.1. Data Validation
1.4.3.2. Market Size Estimation
1.4.3.3. Market Forecast Model
1.4.4. Quality Assessment
2. Introduction: Clinical Trial Supplies
3. Executive Summary
3.1. Global Market Scenario
3.2. Segment Market Scenario
3.3. Geographic Market Scenario
3.4. COVID-19 Impact
3.5. Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4
5. Market Environment Analysis
5.1. Porter’s 5 Forces Analysis
5.2. PESTEL Analysis
5.3. Value Chain Analysis
5.4. SWOT Analysis
5.5. Benchmark
6. COVID-19 Impact Analysis: Clinical Trial Supplies Market
6.1. COVID-19: Overview
6.2. COVID-19 Impact on the Global Market
6.3. COVID-19 Impact on the Regional Markets
7. Market Analysis by Services
7.1. Storage & Retention
7.1.1. Storage & Retention Market Forecast, 2021-2029(USD Million)
7.2. Logistics & Distribution
7.2.1. Logistics & Distribution Market Forecast, 2021-2029(USD Million)
7.3. Comparator Sourcing
7.3.1. Comparator Sourcing Market Forecast, 2021-2029(USD Million)
7.4. Packaging, Labelling & Blinding
7.4.1. Packaging, Labelling & Blinding Market Forecast, 2021-2029(USD Million)
7.5. Manufacturing
7.5.1. Manufacturing Market Forecast, 2021-2029(USD Million)
7.6. Other Services
7.6.1. Other Services Market Forecast, 2021-2029(USD Million)
8. Market Analysis by Phase
8.1. Phase 1
8.1.1. Phase 1 Market Forecast, 2021-2029(USD Million)
8.2. Phase 2
8.2.1. Phase 2Market Forecast, 2021-2029(USD Million)
8.3. Phase 3
8.3.1. Phase 3 Market Forecast, 2021-2029(USD Million)
8.4. Phase 4
8.4.1. Phase 4 Market Forecast, 2021-2029(USD Million)
8.5. BA/BE Studies
8.5.1. BA/BE Studies Market Forecast, 2021-2029(USD Million)
9. Market Analysis by Type
9.1. Biologic drugs
9.1.1. Biologic drugs Market Forecast, 2021-2029(USD Million)
9.2. Small Molecule
9.2.1. Small Molecule Market Forecast, 2021-2029(USD Million)
9.3. Medical Devices
9.3.1. Medical Devices Market Forecast, 2021-2029(USD Million)
10. Market Analysis by Therapeutic Area
10.1. CNS and Mental Disorders
10.1.1. CNS and Mental Disorders Market Forecast, 2021-2029(USD Million)
10.2. Digestive Disorders
10.2.1. Digestive Disorders Market Forecast, 2021-2029(USD Million)
10.3. Blood Disorders
10.3.1. Blood Disorders Market Forecast, 2021-2029(USD Million)
10.4. Cardiovascular Disease
10.4.1. Cardiovascular Disease Market Forecast, 2021-2029(USD Million)
10.5. Metabolic Disorders
10.5.1. Metabolic Disorders Market Forecast, 2021-2029(USD Million)
10.6. Oncology
10.6.1. Oncology Market Forecast, 2021-2029(USD Million)
10.7. Immunology
10.7.1. Immunology Market Forecast, 2021-2029(USD Million)
10.8. Infectious Disorders
10.8.1. Infectious Disorders Market Forecast, 2021-2029(USD Million)
10.9. Others
10.9.1. Others Market Forecast, 2021-2029(USD Million)
11. Market Analysis by End user
11.1. Medical Device Companies
11.1.1. Medical Device Companies Market Forecast, 2021-2029(USD Million)
11.2. Biotechnology & Pharmaceutical Companies
11.2.1. Biotechnology & Pharmaceutical Companies Market Forecast, 2021-2029(USD Million)
11.3. Contract Research Organizations
11.3.1. Contract Research Organizations Market Forecast, 2021-2029(USD Million)
12. Regional Market Analysis
12.1. Regional Market Trends
12.2. Regional Market: Comparative Analysis
13. North America Clinical Trial Supplies Market
13.1. North America Clinical Trial Supplies Market
13.1.1. North America Market Size and Forecast, 2021-2029(USD Million)
13.1.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
13.1.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
13.1.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
13.1.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
13.1.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
13.2. U.S. Clinical Trial Supplies Market
13.2.1. U.S. Market Size and Forecast, 2021-2029(USD Million)
13.2.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
13.2.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
13.2.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
13.2.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
13.2.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
13.3. Canada Clinical Trial Supplies Market
13.3.1. Canada Market Size and Forecast, 2021-2029(USD Million)
13.3.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
13.3.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
13.3.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
13.3.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
13.3.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
14. Europe Clinical Trial Supplies Market
14.1. Europe Clinical Trial Supplies Market
14.1.1. Europe Market Size and Forecast, 2021-2029(USD Million)
14.1.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
14.1.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
14.1.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
14.1.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
14.1.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
14.2. Germany Clinical Trial Supplies Market
14.2.1. Germany Market Size and Forecast, 2021-2029(USD Million)
14.2.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
14.2.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
14.2.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
14.2.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
14.2.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
14.3. UK Clinical Trial Supplies Market
14.3.1. UK Market Size and Forecast, 2021-2029(USD Million)
14.3.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
14.3.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
14.3.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
14.3.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
14.3.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
14.4. France Clinical Trial Supplies Market
14.4.1. France Market Size and Forecast, 2021-2029(USD Million)
14.4.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
14.4.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
14.4.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
14.4.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
14.4.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
14.5. Spain Clinical Trial Supplies Market
14.5.1. Spain Market Size and Forecast, 2021-2029(USD Million)
14.5.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
14.5.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
14.5.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
14.5.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
14.5.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
14.6. Italy Clinical Trial Supplies Market
14.6.1. Italy Market Size and Forecast, 2021-2029(USD Million)
14.6.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
14.6.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
14.6.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
14.6.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
14.6.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
14.7. Rest of Europe Clinical Trial Supplies Market
14.7.1. Rest of Europe Market Size and Forecast, 2021-2029(USD Million)
14.7.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
14.7.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
14.7.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
14.7.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
14.7.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
15. Asia Pacific Clinical Trial Supplies Market
15.1. Asia Pacific Clinical Trial Supplies Market
15.1.1. Asia Pacific Market Size and Forecast, 2021-2029(USD Million)
15.1.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
15.1.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
15.1.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
15.1.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
15.1.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
15.2. Japan Clinical Trial Supplies Market
15.2.1. Japan Market Size and Forecast, 2021-2029(USD Million)
15.2.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
15.2.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
15.2.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
15.2.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
15.2.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
15.3. China Clinical Trial Supplies Market
15.3.1. China Market Size and Forecast, 2021-2029(USD Million)
15.3.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
15.3.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
15.3.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
15.3.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
15.3.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
15.4. India Clinical Trial Supplies Market
15.4.1. India Market Size and Forecast, 2021-2029(USD Million)
15.4.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
15.4.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
15.4.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
15.4.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
15.4.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
15.5. South Korea Clinical Trial Supplies Market
15.5.1. South Korea Market Size and Forecast, 2021-2029(USD Million)
15.5.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
15.5.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
15.5.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
15.5.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
15.5.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
15.6. Australia Clinical Trial Supplies Market
15.6.1. Australia Market Size and Forecast, 2021-2029(USD Million)
15.6.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
15.6.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
15.6.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
15.6.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
15.6.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
15.7. Rest of Asia Pacific Clinical Trial Supplies Market
15.7.1. Rest of Asia Pacific Market Size and Forecast, 2021-2029(USD Million)
15.7.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
15.7.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
15.7.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
15.7.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
15.7.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
16. Latin America Clinical Trial Supplies Market
16.1. Latin America Clinical Trial Supplies Market
16.1.1. Latin America Market Size and Forecast, 2021-2029(USD Million)
16.1.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
16.1.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
16.1.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
16.1.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
16.1.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
16.2. Brazil Clinical Trial Supplies Market
16.2.1. Brazil Market Size and Forecast, 2021-2029(USD Million)
16.2.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
16.2.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
16.2.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
16.2.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
16.2.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
16.3. Mexico Clinical Trial Supplies Market
16.3.1. Mexico Market Size and Forecast, 2021-2029(USD Million)
16.3.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
16.3.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
16.3.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
16.3.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
16.3.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
16.4. Argentina Clinical Trial Supplies Market
16.4.1. Argentina Market Size and Forecast, 2021-2029(USD Million)
16.4.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
16.4.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
16.4.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
16.4.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
16.4.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
16.5. Rest of Latin America Clinical Trial Supplies Market
16.5.1. Rest of Latin America Market Size and Forecast, 2021-2029(USD Million)
16.5.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
16.5.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
16.5.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
16.5.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
16.5.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
17. MEA Clinical Trial Supplies Market
17.1. MEA Clinical Trial Supplies Market
17.1.1. MEA Market Size and Forecast, 2021-2029(USD Million)
17.1.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
17.1.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
17.1.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
17.1.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
17.1.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
17.2. GCC Clinical Trial Supplies Market
17.2.1. GCC Market Size and Forecast, 2021-2029(USD Million)
17.2.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
17.2.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
17.2.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
17.2.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
17.2.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
17.3. South Africa Clinical Trial Supplies Market
17.3.1. South Africa Market Size and Forecast, 2021-2029(USD Million)
17.3.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
17.3.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
17.3.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
17.3.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
17.3.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
17.4. Rest of MEA Clinical Trial Supplies Market
17.4.1. Rest of MEA Market Size and Forecast, 2021-2029(USD Million)
17.4.1.1. Market Size and Forecast by Services, 2021-2029(USD Million)
17.4.1.2. Market Size and Forecast by Phase, 2021-2029(USD Million)
17.4.1.3. Market Size and Forecast by Type, 2021-2029(USD Million)
17.4.1.4. Market Size and Forecast by Therapeutic Area, 2021-2029(USD Million)
17.4.1.5. Market Size and Forecast by End user, 2021-2029(USD Million)
18. Competitor Analysis
18.1. Market Share Analysis, 2021 & 2029
18.2. Competitive Mapping
18.3. Key Players Market Place Analysis
18.4. Major Recent Developments
19. Company Profiles
19.1. Thermo Fisher Scientific (US)
19.1.1. Company Snapshot
19.1.2. Company Overview
19.1.3. Financials
19.1.4. Services Benchmarking
19.1.5. Recent Developments
19.2. Catalent, Inc. (US)
19.2.1. Company Snapshot
19.2.2. Company Overview
19.2.3. Financials
19.2.4. Services Benchmarking
19.2.5. Recent Developments
19.3. Parexel (US)
19.3.1. Company Snapshot
19.3.2. Company Overview
19.3.3. Financials
19.3.4. Services Benchmarking
19.3.5. Recent Developments
19.4. Eurofins (France)
19.4.1. Company Snapshot
19.4.2. Company Overview
19.4.3. Financials
19.4.4. Services Benchmarking
19.4.5. Recent Developments
19.5. UDG Healthcare (Ireland)
19.5.1. Company Snapshot
19.5.2. Company Overview
19.5.3. Financials
19.5.4. Services Benchmarking
19.5.5. Recent Developments
19.6. Piramal Pharma Solutions (India)
19.6.1. Company Snapshot
19.6.2. Company Overview
19.6.3. Financials
19.6.4. Services Benchmarking
19.6.5. Recent Developments
19.7. Almac Group (UK)
19.7.1. Company Snapshot
19.7.2. Company Overview
19.7.3. Financials
19.7.4. Services Benchmarking
19.7.5. Recent Developments
19.8. PCI Pharma Services (US)
19.8.1. Company Snapshot
19.8.2. Company Overview
19.8.3. Financials
19.8.4. Services Benchmarking
19.8.5. Recent Developments
19.9. PRA Health Sciences (US)
19.9.1. Company Snapshot
19.9.2. Company Overview
19.9.3. Financials
19.9.4. Services Benchmarking
19.9.5. Recent Developments
19.10. Biocair (UK)
19.10.1. Company Snapshot
19.10.2. Company Overview
19.10.3. Financials
19.10.4. Services Benchmarking
19.10.5. Recent Developments
19.11. Marken (US)
19.11.1. Company Snapshot
19.11.2. Company Overview
19.11.3. Financials
19.11.4. Services Benchmarking
19.11.5. Recent Developments
19.12. Infosys (India)
19.12.1. Company Snapshot
19.12.2. Company Overview
19.12.3. Financials
19.12.4. Services Benchmarking
19.12.5. Recent Developments
19.13. Liveo Research (India)
19.13.1. Company Snapshot
19.13.2. Company Overview
19.13.3. Financials
19.13.4. Services Benchmarking
19.13.5. Recent Developments
19.14. Capsugel (a Lonza Group company) (Switzerland)
19.14.1. Company Snapshot
19.14.2. Company Overview
19.14.3. Financials
19.14.4. Services Benchmarking
19.14.5. Recent Developments
19.15. SIRO Clinpharm (India)
19.15.1. Company Snapshot
19.15.2. Company Overview
19.15.3. Financials
19.15.4. Services Benchmarking
19.15.5. Recent Developments
19.16. Others Prominent Players
20. Conclusion & Recommendations

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Thermo Fisher (US)
  • Catalent Inc. (US)
  • Parexel (US)
  • Eurofins (France) UDG Healthcare (Ireland)
  • Piramal Pharma Solutions (India)
  • Almac Group (UK)
  • PCI Pharma Services (US)
  • PRA Health Sciences (US)
  • Biocair (UK)
  • Eurofins (France)
  • Marken (US)
  • Infosys (India)
  • Liveo Research (India)
  • Capsugel (a Lonza Group company) (Switzerland)
  • SIRO Clinpharm (India)
  • KLIFO A/S (Denmark)
  • Clinigen (UK)
  • Ancillare (US)
  • N-SIDE (Belgium)
  • ADAllen (UK)
  • Rubicon (India)
  • Durbin (UK)
  • Recipharm (Sweden)
  • Seveillar (India)
  • Myonex (India).